Product Information
IPRATROPIUM 0.03% SPRAY is a generic product labeled by Bausch & Lomb Incorporated, priced at $0.4198 per ML under NDC 24208039830. Its NADAC has been published 639 times since Nov 28, 2013.
FDA first approved this application on Mar 31, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
21 ug/1
Manufacturer
Bausch & Lomb IncorporatedNDC
24208039830
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
2/18/2026
Active Ingredients
IPRATROPIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076025FDA Approved
3/31/2003
TE Code
AB
On Market Since
3/31/2003
Pharmacological Classes
Price Statistics
The NADAC for IPRATROPIUM 0.03% SPRAY has been published 639 times since Nov 28, 2013, and over the history we have for it it has declined 38.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4198 per ML |
|---|---|
| All-time high | $0.9493 (Jul 12, 2023) |
| All-time low | $0.4198 (Feb 18, 2026) |
| 52-week high | $0.5706 |
| 52-week low | $0.4198 |
| Median price | $0.7000 |
| Average price | $0.7160 |
| Largest weekly change | +25.7% (Jun 21, 2023) |
| Weeks tracked | 639 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-26.4%
3Y
-37.0%
5Y
-50.0%
All
-38.0%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ipratropium bromide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ipratropium bromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IPRATROPIUM 0.03% SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for IPRATROPIUM 0.03% SPRAY, manufactured by Bausch & Lomb Incorporated, is $0.4198 per ML (NDC 24208039830), effective Feb 18, 2026.
How has the price of IPRATROPIUM 0.03% SPRAY changed over time?
Over the history we have for it, the NADAC for IPRATROPIUM 0.03% SPRAY has declined 38.0%. It has been tracked across 639 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IPRATROPIUM 0.03% SPRAY?
Since Nov 28, 2013, the NADAC for IPRATROPIUM 0.03% SPRAY has ranged from a low of $0.4198 (Feb 18, 2026) to a high of $0.9493 (Jul 12, 2023), with a median of $0.7000 per ML.
Are there cheaper alternatives to IPRATROPIUM 0.03% SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of IPRATROPIUM 0.03% SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures IPRATROPIUM 0.03% SPRAY?
IPRATROPIUM 0.03% SPRAY (NDC 24208039830) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.